Jade Biosciences (JBIO) Preferred Shares Issued (2021)

Name: Jade Biosciences (JBIO) Preferred Shares Issued (2021) | Business Quant
Creator: Business Quant

Jade Biosciences posted quarterly Preferred Shares Issued of $55.5 million for Q2 2021, up 595.59% on a QoQ basis from $8.0 million in Q1 2021.

Jade Biosciences (JBIO) has 1 years of Preferred Shares Issued data on file, last reported at $55.5 million in Q2 2021.

For the quarter ending Q2 2021, Preferred Shares Issued changed N/A year-over-year to $55.5 million; the trailing twelve-month figure through Dec 2021 stood at $63.5 million (changed N/A YoY), and the FY2021 full-year result was $63.5 million, up 890.36% from the prior year.
Preferred Shares Issued for Q2 2021 stood at $55.5 million, up from $8.0 million in the prior quarter.
Across five years, Preferred Shares Issued topped out at $55.5 million in Q2 2021 and bottomed at $8.0 million in Q1 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	-
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	-
7	Evaxion A	62.56 Bn	62.54 Bn	-	-
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	-
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	-
10	Jade Biosciences	1.06 Bn	1.06 Bn	-	-

Download Data 🔒